The hypothesis is that group interaction associated with individual interviews intensify the acquisition of safety skills compared to individual interviews alone in patients with CIR treated by subcutaneous biotherapies.
Selection and inclusion of patients will be done by principal investigator of Rheumatology Department. After verification of inclusion and non-inclusion criteria by principal investigator and signature of consent, patients will be randomized by 1: 1 randomization (centralized randomization by statistician into 2 groups at M0) : 1. Experimental group (individual and group therapeutic education ) * M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management". * M3 (group with 3 to 10 patients) Intensification Biotherapy Education: Workshops : "Subcutaneous injection education" and "biotherapy management". * M6 (individual presential or by phone) Assessment of security skills and questionnaires. * M12 (individual presential or by phone) Assessment of security skills and questionnaires. 2. Control group (individual therapeutic education alone ) : * M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management". * M3 (individual) Intensification Biotherapy Education: "Subcutaneous injection education" and "biotherapy management". * M6 (individual présential or by phone) Assessment of security skills and questionnaires. * M12 (individual présential or by phone) Assessment of security skills and questionnaires. Group session proposed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
120
Individual and group therapeutic education sessions will consist of : * acquisition by patient of self-care skills such as performing subcutaneous injection, * acquisition by patient of safety skills such as identifying symptoms that should lead to consult general practitioner, and stop treatment ...
Chu Clermont-Ferrand
Clermont-Ferrand, France
Change from Baseline Biosecure's score at 6 months after biological treatment initiation
Biosecure questionnaire assesses safety skills regarding infections, vaccinations, and situations of daily life (travel, surgery, pregnancy,…). It's composed of 29 questions about knowledge and 7 scenarios. The response methods are: yes / no / I don't know, with 55 items (score from 0 to 100 points), developed by Therapeutic Education Section of French Society of Rheumatology.
Time frame: at 6 months
Change from Baseline Biosecure's score at 6 months after biological treatment initiation
Biosecure questionnaire assesses safety skills regarding infections, vaccinations, and situations of daily life (travel, surgery, pregnancy,…). It's composed of 29 questions about knowledge and 7 scenarios. The response methods are: yes / no / I don't know, with 55 items (score from 0 to 100 points), developed by Therapeutic Education Section French Society of Rheumatology.
Time frame: at 6 months
Number of hospitalizations for infection during the year, collected from patient (tracking book) and in medical file, at the follow-up at M12
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Time frame: at 12 months
Number of biotherapy stops and number of visits to physician for infection, collected from patient at M6 and M12 (tracking book)
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Time frame: at 6 months and 12 months
Type of infections occurring, collected from patient at M6 and M12 (tracking book )
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: at 6 months and 12 months
Coping evaluated by analogical visual scale at M6 and M12
RAID questionnaire is calculated according to 7 numerical rating scales: pain, functional ability, fatigue, sleep, emotional well-being, physical well-being, and disease management. Each scale is evaluated by a number between 0 and 10. A final RAID score with high values characterize a disturbing state of the patient
Time frame: at 6 months and 12 months
Psychological well-being evaluated by Analogical visual scale at M6 and M12 by RAID questionnaire.
RAID questionnaire is calculated according to 7 numerical rating scales: pain, functional ability, fatigue, sleep, emotional well-being, physical well-being, and disease management. Each scale is evaluated by a number between 0 and 10. A final RAID score with high values characterize a disturbing state of the patient.
Time frame: at 6 months and 12 months
Fear about treatment evaluated by FAIR questionnaire at M6 and M12.
FAIR questionnaire (Fear Assessment in Inflammatory Rheumatic diseases) evaluate the levels of fear (side effects of treatment, disease progress,…) and psychological distress in patients, it be included in clinical trial protocols to measure the impact of specific interventions on psychological distress
Time frame: at 6 months and 12 months
Patient satisfaction evaluated with Patient satisfaction questionnaire
Patient satisfaction questionnaire items are: overall satisfaction of education sessions, quality of content in line with expectations, teaching methods and tools used, course flow, quality of the exchange
Time frame: at 12 month